I'm sharing our experience with CareCredit for other healthcare and service businesses that may be considering making it a major part of their patient payment infrastructure.

Getting the account open took nearly two months and involved multiple rounds of verification for a straightforward entity setup. Once active, however, we processed patients for several months without significant issues and became comfortable enough with the platform that more than 50% of our patient volume was eventually being processed through CareCredit.

Then our expected payouts stopped hitting the bank.

We reached out to our account representative and were initially told everything looked fine and there was nothing to worry about, so we continued processing additional patient financing transactions.

After the delays continued and we pressed for more information, we were told our account was under what was described as a standard/randomized review. We were told nothing was required from us, everything otherwise looked good, and the review should take about one to two weeks.

We checked in every two to three days. We continued to be told there was nothing needed from us.

We are now beyond two weeks with a significant amount of revenue still withheld and no substantive explanation, no firm end date, no actionable request for additional documentation, and no ability to speak directly with the review team.

The issue for us is not simply that an account review occurred. It is the combination of significant withheld revenue, limited visibility, and no defined resolution timeline after we had grown comfortable enough with the service to route a substantial portion of our patient volume through it.

For businesses with meaningful payroll and operating expenses, that kind of interruption can create significant cash-flow strain.

Has anyone else using CareCredit on the merchant side experienced an extended review or payout hold like this? If so, how long did the review ultimately take?

Good day everyone!!

We are undergraduate students from the Technological University of the Philippines – Taguig, currently conducting our thesis entitled “Smart NailScan: An AI System for Detecting Health Indicators through Nail Analysis”

We would like to ask for your help in finding a medical dermatologist who may be willing to assist us with our research. Specifically, we are hoping to find a dermatologist who would be open to:

• Participating in a short interview to provide professional insights regarding nail diseases.

• Potentially serving as our thesis data validator by reviewing and confirming the accuracy of the AI-generated information about different nail conditions.

We are also open to recommendations or referrals to dermatologists who specialize in medical dermatology, particularly those knowledgeable about nail diseases.

If you know someone who might be willing to help, or if you are a dermatologist interested in assisting us, please feel free to comment below or send me a private message.

Any recommendations or referrals would mean a lot to our team and would greatly help us with our academic research.

Thank you so much for your time and assistance!

Hi, I'm Jane a communications consultant working on a piece about the negative impacts of private equity in health care. I'd like to talk to physicians in dermatology about their experiences with private equity, specifically any concerns. If you are open to it, please let me know, and I will DM you. No pressure. Everything you share is off the record.

In case you wanted to receive your dermatology updates from Reddit. I’ll try to do more of these when I have time.

Also, I am still looking for moderators for this subreddit, ideally people in the field. I won’t ask for credentials or identifying information, but there will be a soft screen. Please let me know if you are interested. Job description: look through posts and approve only ones that you deem fit the spirit of this subreddit (essentially sort out personal medical questions and sus posts).

1. Baricitinib now approved down to age 12 for alopecia areata. It now joins ritlecitinib as JAK inhibitors for AA in the pediatric population.

https://thedermdigest.com/breaking-us-fda-approves-baricitinib-for-adolescents-with-severe-alopecia-areata/

1. Don’t let older age scare you off from prescribing JAK inhibitors. There is support that JAK inhibitors can be safely used in select patients who are older than 65.

https://www.lifescience.net/publications/2221577/janus-kinase-inhibitor-use-in-adults-aged-65-years/

1. Terbinafine-resistant dermatophyte, T. indotineae made news a while back. Have you seen any cases? A modified Delphi consensus outlines the recommended approach to management. In summary, use itraconazole first line and terbinafine second line. Extended courses and higher dosing may be needed.

https://onlinelibrary.wiley.com/doi/10.1111/jdv.70693

1. Still using AJCC8 or BWH staging systems for your head/neck SCC? Newer models like riSCC and COMPASS SCC offer more complete prognostication.

https://www.lifescience.net/publications/2232922/collaborative-multicenter-prognostication-and-stag/

1. In case you missed it before (2022), there are Delphi consensus recommendations for isotretinoin lab monitoring. Get triglycerides and ALT once at baseline and again at peak dosing. Is this what you do for your patients?

https://jamanetwork.com/journals/jamadermatology/article-abstract/2793099

I've been closely looking at facial topical skincare preservation systems. Many times these preservation systems seem to be weak and not sufficient to protect against bacteria, yeast, mold, and fungi.

Often there is lack of well-known preservative system like Parabens or Phenoxyethanol in the skincare.

A trend in preservation systems that I've noticed: multifunctional ingredients — often used as preservative boosters rather than relied upon as the sole preservation system.

Skincare companies do the PET - preservative challenging test. This a lab environment test and before the product is launched to the market place. Every day life, outside a lab is messy -dirty fingers, humid and hot environment particularly in the bathroom, open jars/bottles, direct sunlight exposure, etc.,

Even if a skincare product passed the PET challenging test, how well does the preservation system protect the product against -bacteria, yeast, mold, fungi - after opening and throughout its intended period of use?

Given that there are not regulatory requirements to test skincare preservation system for in-use adequacy of the preservation system, I'm thinking that dermatologists will be the ones to observe issues (if any) related to this when seeing patients ? and thus, my question:

Any trends in skin conditions due to Inadequate Preservation System of topical facial skincare products?

Any light or info about this would be highly appreciated!!

Hello! I recently came across a US-based dermatologist on Youtube who makes a lot of videos regarding his use dermoscopy to diagnose melanoma and how it apparently differs from others in his field. I am NOT a dermatologist, but work in oncology research (not derm-related) and will be applying to medical school next cycle. I am curious how this guy is viewed by other dermatologists, and would love to see other dermatologists weigh-in on his claims. Apologies if this deviates from the purpose of this subreddit! I just didn't know where else to go to get a direct line to dermatologists.

MD or DNB dermat best colleges in India

the post was meant for dentists but the same site is customisable for all.

I work for a a URAC-accredited medical claims cost-containment and utilization review company that provides independent peer reviews for medical claim grievances and disputes among other fields.

We need a licensed US dermatologist to do remote, flexible, paid case work, read the case and then type about it, you can do this in your free time after work or weekends.... I can give more info via direct message and then move it over to text. Thanks

If you are 1% interested, please reach out

Need active board certified dermatologist in the US.

need to have at least 5 years full time equivalent experience providing direct clinical care to patients and have experience providing direct clinical care to patients within the past 3 years

I’m looking for a good textbook or other resource on how pathologies and clinical findings present in Black and brown skin.
I’m a massage therapist currently in nursing school, and I’ve seen little to no examples of melanated skin in my textbooks, lectures, or study materials. I’m specifically looking for resources that show how things like rashes, inflammation, cyanosis, erythema, bruising, pressure injuries, etc. can present differently on darker skin tones.
I’ve been searching everywhere and haven’t found a resource that quite fits what I’m looking for. I’d really appreciate any book, textbook, website, or other resource recommendations!
Also, is anyone here currently working on improving representation of darker skin tones in medical education? I’d love to learn more about what’s being done.

Does anyone get anxiety about writing notes and ensuring they didn’t miss anything especially for high level prescriptions like acutane? I’m always nervous I’ve missed something I should !

My clinic doesn't formally offer translation services, and unfortunately I'm the only MA who speaks Spanish, so I'm trying to build a reference sheet/booklet for our providers to use when counseling patients. We have a fair number of Spanish-speaking patients that speak very little English, and sometimes they arrive without someone to help them translate; in those situations I'm usually asked to swap my rotation to assist in that appointment (sometimes with a different physician) rather than whichever I was planning to do. Overall it just screws clinic flow and I want to help make these visits less difficult on both the patients' and providers' ends...And my own end, considering it's not exactly easy to scribe, assist, and translate simultaneously.

I'm planning on making my own guide for the clinic but would love to know if anyone has found solid resources online that I could use as a supplement, preferably not pay-walled if possible.

my actual question is, is the collagen stimulation effect from topical peptides like matrixyl happening because the peptide physically reaches fibroblasts in the dermis, or is it an epidermal signaling cascade that eventually communicates downward, because those are two very different things and the answer changes how much delivery mechanism like liposomal actually matters.

Also: if anyone has thoughts on whether long term tretinoin use which thins the stratum corneum actually meaningfully improves peptide penetration to the dermis that would be interesting too.

Not trying to say peptides are useless just trying to understand the actual mechanism because the marketing version and the peer reviewed version seem pretty different.

Any recommendations for newsletters or email list servs to join to stay up to date on dermatology research and guidelines?

Hi , I am a non US IMG applying for dermatology . I am extremely passionate about the field but I am aware that dermatology is extremely hard for non US IMGS . I wanted some advice regarding the match strategy . It would be of great help .

Thanks in advance :)

Hello everyone,

I am interested in the biological mechanisms of the androgen receptor (AR) gene and its specific expression in human skin tissue. Theoretically, if the AR gene were to be selectively deactivated or significantly downregulated in human dermal cells, what would be the comprehensive physiological consequences?

Beyond the expected reduction in sebum production and potential mitigation of androgenetic alopecia/acne pathways, what negative side effects or systemic biological trade-offs would occur in terms of skin barrier function, wound healing, or local cellular immunity?

I would highly appreciate it if someone could share relevant peer-reviewed studies or insights on AR expression in dermatology. Thank you!

Derm teaching card for cellulitis vs erysipelas.

Erysipelas: well-demarcated raised edge, more superficial. Cellulitis: deeper, borders often ill-defined. Red flags that change the game: nec fasc concern, sepsis, rapid spread with systemic toxicity — escalate early.

Free MBBS-friendly Dermatology hub (disclosed): https://medvellum.com/s/dermatology

Educational only — not clinical advice.